find the latest legal job
Monash University Director Workplace Relations
Category: Industrial Relations and Employment Law | Location: All Melbourne VIC
· Exceptional senior leadership role
View details
Personal Injury Lawyer - Melbourne Eastern Suburbs - 2-5 years PAE
Category: Personal Injury Law | Location: Lilydale VIC 3140
· Fulfilling role as part of a small team in a positive workplace
View details
Legal Counsel
Category: Banking and Finance Law | Location: Sydney CBD, Inner West & Eastern Suburbs Sydney NSW
· In-house opportunity · Be part of our engine for success in a high growth business
View details
Trainer/Assessor Diploma of Legal Services
Category: Other | Location: Liverpool NSW 2170
· 3 Days Per Week · 9am - 4pm
View details
Corporate and Commercial Partner
Category: Corporate and Commercial Law | Location: Adelaide SA 5000
· Adelaide CBD · Join a leading Adelaide commercial law firm
View details
Aus medical company acquired

Aus medical company acquired

Mark McNamara

Australia’s largest provider of private cancer care has been sold to a consortium of investors.

Firms: King & Wood Mallesons (Quadrant Private Equity and other Icon Group shareholders); Corrs Chambers Westgarth (QIC Ltd, Goldman Sachs Private Equity, Pagoda Investment)

Deal: A consortium of fund managers has purchased Australian cancer care company Icon Group.

Value: Over $1 billion

Area: M&A

Key players: The KWM team advising the Icon shareholders was led by partner Mark McNamara (pictured), with support from partners Elizabeth Hundt Russell and Tim Sherman; special counsel Alex Elser; senior associate Joseph Power and solicitors Dan Flanagan, Karen Chen and Anthoney Duong.

Deal significance: Icon Group is Australia’s largest provider of private cancer care services. Its integrated model provides medical oncology, radiation oncology and oncology compounding.

KWM advised the majority shareholder of Quadrant Private Equity, as well as other Icon shareholders, on the sale of Icon Group to a consortium comprising QIC Ltd, Goldman Sachs Private Equity and Chinese firm Pagoda Investment.

“We have supported Icon since its foundation investment in 2014, having advised on numerous subsequent bolt-on acquisitions leading up to this sale,” said KWM lead partner Mark McNamara.

“The doctor and management group have done a remarkable job over this period delivering first-class cancer care to patients while also laying a very strong platform for the business’ next period of growth in Asia.”


Promoted content
Recommended by Spike Native Network